Managing Risk In Nanotechnology

This book aims to address how nanotechnology risks are being addressed by scientists, particularly in the areas of human health and the environment and how these risks can be measured in financial terms for insurers and regulators. It provides a comprehensive overview of nanotechnology risk measurement and risk transfer methods, including a chapter outlining how Bayesian methods can be used. It also examines nanotechnology from a legal perspective, both current and potential future outcomes. The global market for nanotechnology products was valued at $22.9 billion in 2013 and increased to about $26 billion in 2014. This market is expected to reach about $64.2 billion by 2019, a compound annual growth rate (CAGR) of 19.8% from 2014 to 2019. Despite the increasing value of nanotechnologies and their widespread use, there is a significant gap between the enthusiasm of scientists and nanotechnology entrepreneurs working in the nanotechnology space and the insurance/regulatory sector. Scientists are scarcely aware that insurers/regulators have concerns about the potential for human and environmental risk and insurers/regulators are not in a position to access the potential risk. This book aims to bridge this gap by defining the current challenges in nanotechnology across disciplines and providing a number of risk management and assessment methodologies. Featuring contributions from authors in areas such as regulation, law, ethics, management, insurance and manufacturing, this volume provides an interdisciplinary perspective that is of value to students, academics, researchers, policy makers, practitioners and society in general.

Should you adopt nanotechnology? If you have already adopted it, what do you need to know? What are the risks? Nanomaterials and nanotechnologies are revolutionizing the ways we treat disease, produce energy, manufacture products, and attend to our daily wants and needs. To continue to capture the promise of these transformative products, however, we need to ask critical questions about the broader impacts of nanotechnology on society and the environment. Exploring these questions, the second edition of Nanotechnology: Health and Environmental Risks gives you the latest tools to understand the risks of nanotechnology and make better decisions about using it. Examining the state of the science, the book discusses what is known, and what still needs to be understood, about nanotechnology risk. It looks at the uses of nanotechnology for energy, industry, medicine, technology, and consumer applications and explains how to determine whether there is risk—even when there is little reliable evidence—and how to manage it. Contributors cover a wide range of topics, including: Current concerns, among them perceived risks and the challenges of evaluating emerging technology A historical perspective on product safety and chemicals policy The importance of being proactive about identifying and managing health and environmental risks during product development How the concepts of sustainability and life cycle assessment can guide nanotechnology product development Methods for evaluating nanotechnology risks, including screening approaches and research How to manage risk when working with nanoscale materials at the research stage and in occupational environments What international organizations are doing to address risk issues How risk assessment can inform environmental decision making Written in easy-to-understand language, without sacrificing complexity or scientific accuracy, this book offers a wide-angle view of nanotechnology and risk. Supplying cutting-edge approaches and insight, it explains what types of risks could exist and what you can do to address them. What’s New in This Edition Updates throughout, reflecting advances in the field, new literature, and policy developments A new chapter on nanotechnology risk communication, including insights into risk perceptions and the mental models people use to evaluate technological risks An emphasis on developing nanotechnology products that are sustainable in the long term Advances in the understanding of nanomaterials toxicity Cutting-edge research on occupational exposure to nanoparticles Changes in the international landscape of organizations working on the environmental, health, and safety aspects of nanotechnologies

Many potential questions regarding the risks associated with the development and use of wide-ranging technologies enabled through engineered nanomaterials. For example, with over 600 consumer products available globally, what information exists that describes their risk to human health and the environment? What en- neering or use controls can be deployed to minimize the potential environmental health and safety impacts of nanomaterials throughout the manufacturing and product lifecycles? How can the potential environmental and health benefits of nanotechnology be realized and maximized? The idea for this book was conceived at the NATO Advanced Research Workshop (ARW) on “Nanomaterials: Environmental Risks and Benefits and Emerging Consumer Products. ” This meeting – held in Algarve, Portugal, in April 2008 – started with building a foundation to harmonize risks and benefits associated with nanomaterials to develop risk management approaches and policies. More than 70 experts, from 19 countries, in the fields of risk assessment, decision-analysis, and security discussed the current state-of-knowledge with regard to nanomaterial risk and benefits. The discussion focused on the adequacy of available risk assessment tools to guide nanomaterial applications in industry and risk governance. The workshop had five primary purposes: Describe the potential benefits of nanotechnology enabled commercial products. Identify and describe what is known about environmental and human health risks of nanomaterials and approaches to assess their safety. Assess the suitability of multicriteria decision analysis for reconciling the benefits and risks of nanotechnology.

Following up on one of the recommendations of the 2009 FAO/WHO expert meeting, the present report reviews national and international activities on the risk analysis of nanomaterials in the food and agriculture sectors that have been carried out since the meeting. It presents national and international risk assessment and risk management approaches that identify and implement strategies to address potential hazards associated with the use of nanotechnology-related products or techniques.

Assessing Nanoparticle Risks to Human Health provides a systematic overview of nanoparticle risks and considers the limitations of this paradigm in a context where extreme uncertainties prevail. As well as exploring conventional risk assessment methodology, the contributing authors investigate several alternate approaches. The adequacy of current frameworks for risk management and regulatory oversights, including corporate approaches in the US and EU, are explored, and suggestions are made as to how these frameworks can be modified to make them more efficient and effective. Presenting a coherent framework for analysis of the available information, this book presents the latest scientific understanding of the toxicity and health effects of nanoparticles, the technical issues relating to exposure assessment and management, and the ways in which the current risk paradigm can be used/modified to deal with the challenges of nanoparticle risks. All chapters of this new edition have been thoroughly updated to reflect the many changes in the field since the first edition. Additions and updates in the second edition of the book include: New exposure assessment strategies for nanomaterials including life cycle exposure assessment approaches and detailed information on nanoparticle exposure control and protection in the workplace. A state-of-the-art scientific update on the hazard and risk assessment of nanomaterials: discussion of key additional publications on the toxicology and biokinetics of nanomaterials; available data and methods to characterize the health hazard and risk of exposure to nanomaterials in the workplace; additional examples of the use of such data and methods to develop occupational safety and health guidance; and discussion of progress to date, ongoing efforts, and remaining challenges in nanomaterials hazard and risk characterization. New studies on the use of expert judgment in nanotechnology. Quantitative data from Lawrence Berkeley National Laboratory’s 4-phase study. A description and evaluation of new CB tools and new ISO technical specifications. A comprehensive update of the legal frameworks in the US and the EU. With the second edition of Assessing Nanoparticle Risks to Human Health Prof. Ramachandran provides researchers and practitioners producing or using nanoparticles, or those involved in nanomaterials risk assessments, technology, health science, policy, safety, environment and regulatory aspects an invaluable reference to adopt the right technologies and strategies and to comply to legal frameworks and regulations. For policy makers and advisory firms it provides the knowledge needed to advise on compliance with or development of new regulations on nanomaterials. Makes essential reading for risk assessment professionals, companies working with nanoparticles, nanotechnology research groups and regulators Explores the use of risk assessment methodologies in an occupational health setting, and their limitations Provides a framework for evidence-based decision making in a context with many uncertainties

Nanotechnology Environmental Health and Safety tackles – in depth and in breadth – the complex and evolving issues pertaining to nanotechnology's environmental health and safety (EHS). The chapters are authored by leaders in their respective fields, providing thorough analysis of their research areas. The diverse spectrum of topics include nanotechnology EHS issues, financial implications, foreseeable risks including exposure, dosage and hazards, and the implications of occupational hygiene precautions and consumer protections. The book includes real-world case studies, wherever practical, to illustrate specific issues and scenarios encountered by stakeholders positioned on the front-lines of nanotechnology-enabled industries. These case studies will appeal to, and resonate with, laboratory scientists, business leaders, regulators, service providers, and postgraduate researchers. Reviews toxicological studies and industrial initiatives, supported by numerous case studies Covers new generation of nanoparticles and significantly expands on existing material from second edition Only edited volume to collect research on the regulatory and risk implications of a wide array of industrial, environmental and consumer nanomaterials

This book tackles the debate over nanotechnology's environmental health and safety (EHS) by thoroughly explaining EHS issues, financial implications, foreseeable risks (i.e. exposure, dose, hazards of nanomaterials), and the implications of occupational hygiene precautions and consumer protections. Real-world case studies are included, e.g. the discussion of a leading chemical company's unusual pairing with the USA's largest environmental NGO, and an innovative program designed for small- to mid-sized businesses, which became a model approach for proactive nanotechnology EHS risk man.

Nanotechnology seems to escape boundaries and definitions. The 'Rush to Nanoscale' spreads throughout different sites and arenas, involving a multiplicity of actors, meanings and spaces in which they emerge. The uncertainty of nanotechnology appears to be both a condition and a consequence of this situation. This volume adds to the collective effort of charting the multiple and heterogeneous dimensions that characterize nanotechnology, by analyzing the numerous modalities through which different stakeholders and actors provide definitions, attribute meaning and sense to nano-enabled innovations. The chapters of the book attempt to highlight how nanotechnologies, their discourse, and their actual and potential implications cannot be isolated in laboratories, factories, markets and separate discussion arenas.